Search

Bleeding and Thrombosis

The objectives of the SWG on ‘Bleeding and Thrombosis’ are:

To promote education in the field of blood coagulation, including mechanisms, prevention, and treatment of bleeding and thrombotic disorders.

Read more

EHA reaffirms commitment to hematology's future with new brand identity

The European Hematology Association (EHA) is thrilled to announce the launch of our new brand identity. This includes a refreshed logo, updated color palette, and a new slogan, marking a significant milestone in our journey.

Read more

EHA collaborates with THD to provide critical aid to hematologists

The Hague (Netherlands), June 23, 2023. The European Hematology Association (EHA) is proud to announce its partnership with the Türk Hematoloji Derneği (THD) in a joint effort to support hematologists working in earthquake-affected areas in Türkiye and Syria.

Read more

The HARMONY project: learning to work in BIG (DATA) teams

The HARMONY project: learning to work in BIG (DATA) teams

By Anna Kabanova PhD, YoungEHA committee member

On 26 and 27 September 2019 several YoungEHA members, including myself, had the chance to participate in the 4th General Assembly of the HARMONY Alliance…

Read more

European Hematology Association publishes new journal with Wolters Kluwer

The European Hematology Association, the largest Europe-based association of hematologists, launched its new journal HemaSphere with publisher Wolters Kluwer at the 22nd Annual Congress of EHA in Madrid.

Read more

Lighting the Flame program

Spark your interest in hematology by joining our free training program for medical students, interns, and residents who have not yet chosen a specialty.

Read more

Membership

Boost your career, fast-track your development, and make new connections by joining a pioneering European hematology organization with global reach.

Read more

Without access to treatment, can we truly innovate in rare diseases?

Interview with Giampaolo Merlini

There have been many developments on rare diseases since the EU Orphan Medicinal Products Regulation came into force in 2000. As the European Commission is evaluating its effectiveness, EHA discussed with Prof.

Read more